Ardelyx (ARDX) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.96% |
| Dec 31, 2025 | -7.26% |
| Sep 30, 2025 | -5.52% |
| Jun 30, 2025 | -3.09% |
| Mar 31, 2025 | 0.84% |
| Dec 31, 2024 | -0.21% |
| Sep 30, 2024 | -12.96% |
| Jun 30, 2024 | -8.45% |
| Mar 31, 2024 | -5.97% |
| Dec 31, 2023 | -1.86% |
| Sep 30, 2023 | 2.40% |
| Jun 30, 2023 | 9.72% |
| Mar 31, 2023 | -0.45% |
| Dec 31, 2022 | 1.55% |
| Sep 30, 2022 | 6.86% |
| Jun 30, 2022 | 11.44% |
| Mar 31, 2022 | 12.35% |
| Dec 31, 2021 | 10.29% |
| Sep 30, 2021 | 9.25% |
| Jun 30, 2021 | -3.21% |
| Mar 31, 2021 | -0.75% |
| Dec 31, 2020 | -11.75% |
| Sep 30, 2020 | -7.53% |
| Jun 30, 2020 | -7.67% |
| Mar 31, 2020 | -17.82% |
| Dec 31, 2019 | -18.20% |
| Sep 30, 2019 | 1.57% |
| Jun 30, 2019 | -1.02% |
| Mar 31, 2019 | -35.47% |
| Dec 31, 2018 | -37.31% |
| Sep 30, 2018 | -51.28% |
| Jun 30, 2018 | -55.04% |